Cellectar Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Cellectar Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Cellectar Biosciences Inc
Rating: 1.36933325
Author: Trendlyne DVM scores

about

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

3.79 -0.02 (-0.52%)

81.61% Fall from 52W High

26,504

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

10.3 / 100

Technically Neutral

44.4 / 100

No estimates available

Cellectar Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cellectar Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid d...

81.61% Fall from 52W High

SWOT Analysis

Cellectar Biosciences Inc Live Price Chart